Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

The potential anchor tenant, a biotech firm based in the innovation district, is being recruited by other cities.

Global biopharmaceutical company Gilead Sciences Inc. (Nasdaq: GILD) is closing its office in Seattle and laying off 72 ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.